Dementia care in the United States is projected to cost $818 billion in 2026, according to a USC-led study published in *Alzheimer’s & Dementia* journal and released on June 24, 2026. This staggering figure represents one of the largest economic burdens facing American families and the health care system—yet most of it remains invisible in traditional healthcare spending discussions. The reality that emerges from this research is sobering: while the nation spends roughly $222 billion on direct medical and long-term care costs, a far larger share of the burden falls on people living with dementia and their family caregivers through lost quality of life, unpaid care work, and forgone wages.
The study examined the full economic footprint of dementia affecting 5.7 million Americans in 2026 (with 5.1 million aged 65 and older), revealing costs that extend far beyond hospital bills and prescription medications. For a family caring for a relative with dementia, this might mean one spouse leaving their job to provide full-time care while medical co-payments and assisted living costs deplete savings—a scenario that plays out in millions of American households simultaneously, each carrying its own financial and emotional weight. What makes these projections especially significant is that they expose a fundamental mismatch between where dementia costs actually occur and where policy attention typically focuses. Insurance covers about 70 percent of medical and long-term care expenses, leaving substantial gaps that patients and families fill directly from their own resources.
Table of Contents
- Where Does the $818 Billion in Dementia Costs Actually Go?
- The Largest Cost: Quality of Life Losses Worth $320 Billion
- The Hidden Labor: $237 Billion in Unpaid Family Care
- Direct Medical and Long-Term Care: $222 Billion and the Coverage Gap
- Lost Wages and Economic Displacement: $23 Billion Annually
- Insurance Coverage and the Out-of-Pocket Reality
- The Research Methodology and What the 2026 Projections Mean
Where Does the $818 Billion in Dementia Costs Actually Go?
The $818 billion figure breaks down into four distinct categories that reveal very different kinds of burden. The largest single component is quality of life losses experienced by people living with dementia—a category accounting for $320 billion that captures the profound human toll of cognitive decline, loss of independence, and the diminished ability to engage in daily activities and relationships that give life meaning. The second largest component is the $237 billion in unpaid care provided by family members and friends, representing labor that would cost the healthcare system far more if it had to be compensated at market rates for professional caregivers. Direct medical and long-term care services total $222 billion, and lost wages—from both people with dementia who must leave work and their care partners who reduce their own employment—amount to $23 billion annually. This breakdown is essential for understanding why dementia ranks as one of the costliest conditions in America.
If only the $222 billion in direct medical costs were counted, dementia would still be among the top healthcare expenses, comparable to cancer or heart disease. But the reality is broader and more burdensome: the vast majority of dementia’s economic impact flows through families and individuals rather than through the healthcare system’s standard billing channels. A family supporting a parent with moderate dementia might spend $4,000 to $6,000 monthly on care, medications, and facility fees—but the study’s accounting includes an additional hidden cost: the income their adult child sacrificed by leaving a job to provide supervision and assistance. Understanding these categories matters because it shapes what solutions are actually feasible. You cannot simply add more Medicare coverage and solve the problem, because most of the cost is embedded in lost productivity and care burdens that insurance cannot directly address. This reality has profound policy implications that policymakers are still grappling with.
The Largest Cost: Quality of Life Losses Worth $320 Billion
The $320 billion attributed to quality of life losses represents dementia’s most significant economic category, yet it is also the most difficult to quantify and the easiest for policymakers to overlook. This figure attempts to monetize the suffering and functional decline that people with dementia experience—the loss of the ability to recognize loved ones, to live independently, to pursue interests and hobbies, and to participate in community life. For individuals and families, this is not an abstract economic metric; it is the lived reality of progressive cognitive decline that no medical intervention currently reverses. The challenge with this category is that it sits at the intersection of healthcare economics and human experience in ways that standard medical billing cannot capture.
A person with advanced Alzheimer’s disease may receive excellent medical care for their physical health—infections are treated, medications are managed—while experiencing profound loss of the self that medical interventions cannot address. The economic models attempting to quantify this loss rely on methodologies that ask researchers to assign dollar values to independence, memory, and the ability to recognize family members. While these models have legitimate uses for policy analysis, they are inherently limited in capturing the full scope of what is actually lost. One important limitation to recognize: this category of costs is not something individuals or families can directly reduce through better planning or more aggressive treatment. Unlike some medical costs that might be lowered through preventive care or different treatment choices, quality of life losses from dementia accumulate as the disease progresses, making it essential that families understand that some costs—this major one—are largely outside their control or ability to prevent.
The Hidden Labor: $237 Billion in Unpaid Family Care
The $237 billion in unpaid care provided by family members and friends represents an enormous transfer of labor from the formal healthcare and long-term care systems to individual families. This is not speculative—it reflects the reality that approximately 16 million Americans provide unpaid care to adults with dementia, and the vast majority of dementia care, especially in early and moderate stages, happens at home or in community settings, provided by family members with minimal compensation or formal recognition. To understand what $237 billion in unpaid care actually means, consider a specific example: An adult daughter whose mother has moderate dementia might spend 30-40 hours per week on caregiving tasks—medication management, meal preparation, personal hygiene assistance, transportation to medical appointments, and supervision to prevent wandering or unsafe behavior. If this same work were provided by a paid home health aide at prevailing wage rates (typically $15-20 per hour), it would cost $22,500 to $41,600 annually for that one person.
Multiply that across millions of family caregivers, and the economic scale becomes evident. Many family caregivers are providing these services while also maintaining employment, meaning they are essentially working a second job without compensation—a situation that contributes significantly to caregiver burnout, health problems among caregivers themselves, and family financial stress. The warning embedded in these figures is that the current long-term care system in America is fundamentally dependent on family labor that cannot sustainably continue at current levels. As demographic patterns shift and multigenerational households become less common, this unpaid care burden falls increasingly on smaller numbers of adult children (more often daughters), many of whom are simultaneously in peak earning years or approaching retirement. The $237 billion figure represents a form of invisible subsidy that families provide to the healthcare system—a burden that many families cannot sustain without serious consequences to their own financial security and health.
Direct Medical and Long-Term Care: $222 Billion and the Coverage Gap
The $222 billion in direct medical and long-term care costs is where dementia’s burden intersects most directly with the healthcare system and insurance landscape. This category includes physician visits, diagnostic testing, prescription medications, memory care facility care, assisted living, and nursing home care. It is substantial, but it is also where the system has some established mechanisms for cost management and coverage—though those mechanisms are far from perfect. Medicare and Medicaid together cover approximately 70 percent of these medical and long-term care costs, translating to roughly $154 billion in public insurance expenditure. However, this leaves a substantial gap: approximately $46 billion in out-of-pocket costs paid directly by patients and families. For many families, this out-of-pocket burden is the most immediate and disruptive financial consequence of dementia.
A memory care facility in most American markets costs $4,500 to $8,000 monthly—or $54,000 to $96,000 annually. While Medicare may cover some skilled nursing care after a hospital stay, it does not typically cover custodial care in assisted living or memory care facilities, leaving families to pay these costs until their assets are depleted enough to qualify for Medicaid. The comparison is striking: a family with a parent requiring memory care facility placement will face several years of substantial out-of-pocket costs before Medicaid becomes available, while the same family with a parent requiring similar levels of care in a hospital or skilled nursing facility would have much of that covered through Medicare. This coverage gap creates genuine financial hardship. A moderately affluent family with $400,000 in retirement savings and one parent with dementia requiring facility care might find those savings exhausted within 4-5 years, leaving the surviving spouse with minimal security. The current system essentially requires families to spend down their assets to poverty levels before public insurance assistance becomes available—a policy outcome that many view as fundamentally unjust and economically wasteful.
Lost Wages and Economic Displacement: $23 Billion Annually
The $23 billion in lost wages reflects two distinct but related impacts: income forgone by people with dementia who must leave employment as cognitive decline makes work impossible, and income forgone by family caregivers who reduce work hours or leave employment entirely to provide care. While this figure is smaller in absolute terms than the other cost categories, it represents some of the most direct and measurable economic consequence of dementia on families’ ability to maintain their standard of living. For the person with dementia, cognitive decline typically becomes incompatible with sustained employment during the moderate stage of the disease. Someone diagnosed with mild cognitive impairment at age 62 might work another 3-5 years before symptoms progress to the point where employment is no longer feasible, forfeiting 10-15 years of potential earnings and accelerating the onset of Medicare eligibility. For family caregivers, the wage loss reflects a different pattern: many adult children caring for parents with dementia reduce work hours from full-time to part-time employment, take unpaid leave, or exit the workforce entirely during the most intensive care periods.
A caregiver earning $65,000 annually who reduces to part-time work to provide parental care loses roughly $32,500 annually in income. Multiply this across millions of caregivers, many of whom are in their peak earning years between ages 45 and 65, and the lifetime earnings loss becomes enormous. The warning here is that wage loss disproportionately impacts families with lower to moderate incomes, for whom the loss of even one household income can be catastrophic. Families with substantial wealth can absorb lost wages more easily by drawing on savings or investments; families living paycheck to paycheck cannot. The $23 billion figure masks significant inequality in how dementia’s economic burden is distributed across socioeconomic groups.
Insurance Coverage and the Out-of-Pocket Reality
While Medicare and Medicaid cover approximately 70 percent of medical and long-term care costs, the distribution of that coverage is uneven and leaves significant gaps that vary based on the type of care needed and the individual’s financial resources. Medicare primarily covers acute medical care and skilled nursing care following hospitalization; it does not cover custodial care in assisted living facilities or memory care units. Medicaid covers long-term care services but only after an individual has spent down their assets to near-poverty levels, a process that can take several years and requires navigating complex eligibility rules. A concrete example illustrates how these coverage gaps affect families in practice: A 72-year-old woman with Alzheimer’s disease has Medicare coverage. She develops a urinary tract infection and is hospitalized; Medicare covers the hospital stay and up to 100 days of skilled nursing care if she meets specific criteria.
However, after discharge, she requires ongoing supervision and assistance with activities of daily living—she cannot safely remain at home alone but does not need the level of medical care provided in a skilled nursing facility. Her family places her in a memory care community that costs $6,000 monthly. Medicare does not cover this care; Medicaid will eventually cover it but only after her assets (excluding her home) fall below about $2,000 in most states. Her family pays out of pocket until that point is reached. Her total out-of-pocket cost during this waiting period might be $60,000-$120,000, representing a significant financial shock to middle-class families.
The Research Methodology and What the 2026 Projections Mean
The USC-led study published in *Alzheimer’s & Dementia* journal used comprehensive methodology to estimate dementia costs for 2026, building on previous research by Thunell and colleagues. The projections are based on data about the prevalence of dementia in the U.S. population, the demographic composition of people with dementia, the types and intensity of care different individuals require, and the costs associated with each category of care and support. The study’s inclusion of quality of life losses and unpaid care work represents a more comprehensive accounting than traditional healthcare cost analyses that focus only on direct medical expenses.
It is important to note that these are projections—informed estimates for a future year based on current knowledge about dementia prevalence, care patterns, and costs. The actual 2026 costs may vary based on factors including changes in dementia prevalence rates, shifts in how care is provided, inflation in healthcare costs, and policy changes affecting insurance coverage. Additionally, the assignment of dollar values to quality of life losses, while methodologically sound, involves assumptions and modeling choices that reasonable researchers might approach differently. The $818 billion figure should be understood as a comprehensive estimate of dementia’s economic burden rather than a precise prediction—but it is an estimate grounded in substantial research and data analysis, not speculation.
